Dergiler / Turkish Journal of Gastroenterology / 2015 / Cilt: 26 - Sayı: 2

18F-FDG activitiy PET/CT and CA-19.9 levels for the prediction of histopathological features and localization of peri- ampullary tumors

Sayfa
170–175
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The ratio of CA 19-9 levels and SUVmax were found to be higher in cases of poorly differentiated tumors and tumors greater than 2 cm in diameter.Conclusion: A surgical approach to treatment may be considered for patients who have both i) an established or suspected diagnosis of periampullary tumors and ii) low SUVmax and CA 19-9 levels.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: We sought to investigate the roles of maximum standardized uptake value (SUVmax) and serum carbohydrate antigen 19-9 in predicting the histopathological features of periampullary tumors.
📊
Temel Bulgular & Veri:SUVmax was obtained from [(18)F]-fluorodeoxyglucose positron emission tomography computed tomography (18F-FDG PET/CT).
💡
Sonuç & Katkı:The ratio of CA 19-9 levels and SUVmax were found to be higher in cases of poorly differentiated tumors and tumors greater than 2 cm in diameter.Conclusion: A surgical approach to treatment may be considered for patients who have both i) an established or suspected diagnosis of periampullary tumors and ii) low SUVmax and CA 19-9 levels.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: We sought to investigate the roles of maximum standardized uptake value (SUVmax) and serum carbohydrate antigen 19-9 in predicting the histopathological features of periampullary tumors. Materials and Methods: Thirty-four patients with histologically confirmed periampullary tumors were classified into two groups, according to the localizations of their tumors (ampulla Vateri or pancreas). SUVmax was obtained from [(18)F]-fluorodeoxyglucose positron emission tomography computed tomography (18F-FDG PET/CT). SUVmaxand CA 19-9 levels were measured and compared with histopathological features of the tumors. Logistic regression was used to assess the significance and independence of predictive factors.Results: 18F-FDG PET/CT SUVmax (<2.5 vs. >=2.5; p=0.031) and CA 19-9 level (normal vs. elevated; p=0.045) were significantly and independently predictive of the histopathological origin of the tumors (ampulla Vateri vs. pancreas). The ratio of CA 19-9 levels and SUVmax were found to be higher in cases of poorly differentiated tumors and tumors greater than 2 cm in diameter.Conclusion: A surgical approach to treatment may be considered for patients who have both i) an established or suspected diagnosis of periampullary tumors and ii) low SUVmax and CA 19-9 levels.

🔖

Bu Makaleye Atıf Yap

AKCAM, A. T., ÜLKÜ, A., RENCÜZOĞULLARI, A., PARSAK, C. K., YAPAR, Z., DORAN, F., DEMİRYÜREK, H., OKOH, A. K. (2015). 18F-FDG activitiy PET/CT and CA-19.9 levels for the prediction of histopathological features and localization of peri- ampullary tumors. Turkish Journal of Gastroenterology, Cilt: 26 - Sayı: 2, 170–175. https://ajindex.com/articles/410251

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29. [CrossRef ] 2. Hernandez-Jover D, Pernas JC, Gonzalez-Ceballos S, Lupu I, Monill JM, Pérez C. Pancreatoduodenal junction: review of anatomy and pathologic conditions. J Gastrointest Surg 2011; 15: 1269-81. [CrossRef ] 3. Kim K, Chie EK, Jang JY, et al. Prognostic significance of tumor location after adjuvant chemotherapy for periampullary adenocarcinoma. Clin Transl Oncol 2012; 14: 391-5. [CrossRef ] 4. Kang SP, Saif MW. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. JOP 2011; 9: 123-5. 5. Patai A, Heber S, Döbrönte Z, Kovács LG. Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology. Orv Hetil 1992; 133: 1301-7. 6. Böttger T, Hassdenteufel A, Boddin J, Küchle R, Junginger T, Prellwitz W. Value of CA 19-9 tumor marker in differential diagnosis of space-occupying lesions in the head of pancreas. Chirurg 1996; 67: 1007-11. [CrossRef ] 7. Duraker N1, Hot S, Polat Y, Höbek A, Gençler N, Urhan N. CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. J Surg Oncol 2007; 95: 142-7. [CrossRef ] 8. Ballehaninna U, Cahamberlain RS. The clinical utility of CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol 2012; 3: 105-19. 9. Fong ZV, Winter JM. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive. Cancer J 2012; 18: 530-8. [CrossRef ] 10. Poruk KE, Gay DZ, Brown K, et al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med 2013; 13: 340-51. [CrossRef ] 11. Galli C, Basso D, Plebani B. CA 19-9: handle with care. Clin Chem Lab Med 2013; 51: 1369-89. [CrossRef ] 12. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998; 82: 1160-6. [CrossRef ] 13. Nyugen VX, Nyugen CC, Nyugen BD. 18 F-FDG PET/CT imaging of the pancreas: spectrum of diseases. JOP 2011; 12: 557-66. 14. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998; 82: 1160-66. [CrossRef ] 15. Kim MJ, Lee KH, Lee KT et al. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer. Pancreas 2012; 4: 897- 903. [Cros